Axoft Inc.

Axoft is a neurotechnology company developing bio-inspired, implantable brain-computer interfaces (iBCIs) that mimic the soft tissues of the brain. By utilizing ultra-flexible materials, the company aims to reduce the scarring and long-term damage associated with traditional rigid neural implants, enabling stable, high-resolution, and long-term communication with neurons. Beyond its core BCI technology, Axoft has commercialized "Fleuron," a high-performance, biocompatible soft material used in microfluidics and organ-on-chip applications. The company is currently focused on advancing its BCI technology through clinical trials to treat neurological disorders such as paralysis, disorders of consciousness, and neurodegenerative conditions.